629 related articles for article (PubMed ID: 15544855)
1. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
[TBL] [Abstract][Full Text] [Related]
2. The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age.
Dimitrijević M; Stanojević S; Mitić K; Kustrimović N; Vujić V; Miletić T; Kovacević-Jovanović V
Peptides; 2008 Dec; 29(12):2179-87. PubMed ID: 18805447
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
Umeda T; Kanatani A; Iwaasa H
Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
5. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
Gehlert DR; Shaw JL
Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
Spinazzi R; Andreis PG; Nussdorfer GG
Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
[TBL] [Abstract][Full Text] [Related]
7. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
Goumain M; Voisin T; Lorinet AM; Laburthe M
Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y (NPY) modulates oxidative burst and nitric oxide production in carrageenan-elicited granulocytes from rat air pouch.
Dimitrijević M; Stanojević S; Mićić S; Vujić V; Kovacević-Jovanović V; Mitić K; von Hörsten S; Kosec D
Peptides; 2006 Dec; 27(12):3208-15. PubMed ID: 17010476
[TBL] [Abstract][Full Text] [Related]
9. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors.
Teixeira L; Sousa DM; Nunes AF; Sousa MM; Herzog H; Lamghari M
J Cell Biochem; 2009 Aug; 107(5):908-16. PubMed ID: 19459152
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y modulates functions of inflammatory cells in the rat: distinct role for Y1, Y2 and Y5 receptors.
Mitić K; Stanojević S; Kuštrimović N; Vujić V; Dimitrijević M
Peptides; 2011 Aug; 32(8):1626-33. PubMed ID: 21699939
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
12. Molecular evolution of NPY receptor subtypes.
Larhammar D; Salaneck E
Neuropeptides; 2004 Aug; 38(4):141-51. PubMed ID: 15337367
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
Ammar DA; Hughes BA; Thompson DA
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
[TBL] [Abstract][Full Text] [Related]
14. The Galanin N-terminal fragment (1-15) interacts with neuropeptide Y in central cardiovascular control: Involvement of the NPY Y2 receptor subtype.
Díaz-Cabiale Z; Parrado C; Narváez M; Millón C; Puigcerver A; Fuxe K; Narváez JA
Regul Pept; 2010 Aug; 163(1-3):130-6. PubMed ID: 20451563
[TBL] [Abstract][Full Text] [Related]
15. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
J Pharmacol Exp Ther; 1993 Apr; 265(1):172-7. PubMed ID: 8474004
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors.
Movafagh S; Hobson JP; Spiegel S; Kleinman HK; Zukowska Z
FASEB J; 2006 Sep; 20(11):1924-6. PubMed ID: 16891622
[TBL] [Abstract][Full Text] [Related]
17. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
[TBL] [Abstract][Full Text] [Related]
18. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
[TBL] [Abstract][Full Text] [Related]
19. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
[TBL] [Abstract][Full Text] [Related]
20. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains.
Dumont Y; Jacques D; Bouchard P; Quirion R
J Comp Neurol; 1998 Dec; 402(3):372-84. PubMed ID: 9853905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]